GGrantIndex
← Search

Functional Genomics Shared Resource

$1P30FY2023CANIH

University Of Colorado Denver, Aurora CO

Investigators

Linked publications, trials & patents

Paper 39763739Paper 39737640Paper 39726772Paper 39711559Paper 39711135Paper 39684443Paper 39677775Paper 39677720Paper 39677022Paper 39671500Paper 39671496Paper 39630148Paper 39609428Paper 39604567Paper 39603869Paper 39574899Paper 39564580Paper 39554114Paper 39436696Paper 39400608Paper 39384405Paper 39342284Paper 39321266Paper 39311710Paper 39282307Paper 39266537Paper 39264810Paper 39215796Paper 39201277Paper 39191549Paper 39147413Paper 39139560Paper 39136655Paper 39120971Paper 39091762Trial NCT05073848Trial NCT05053737Trial NCT05006040Trial NCT04993859Trial NCT04988490Trial NCT04973007Trial NCT04963283Trial NCT04940468Trial NCT04925193Trial NCT04922112Trial NCT04916990Trial NCT04882111Trial NCT04866758Trial NCT04863092Trial NCT04634110Trial NCT04611022Trial NCT04565457Trial NCT04558138Trial NCT04544592Trial NCT04541407Trial NCT04535102Trial NCT04520867Trial NCT04486573Trial NCT04471363Trial NCT04408092Trial NCT04305366Trial NCT04300478Trial NCT04294693Trial NCT04208243Trial NCT04092803Trial NCT04091867Trial NCT04066218Trial NCT04042935Trial NCT04035408Trial NCT04028167Trial NCT04028063Trial NCT04001101Trial NCT03995082Trial NCT03976193Trial NCT03970226Trial NCT03958565Trial NCT03900793Trial NCT03891654Trial NCT03881098Trial NCT03781154Trial NCT03734653Trial NCT03617679Trial NCT03325634Trial NCT01886859Trial NCT01426334Trial NCT01232829Trial NCT00778167Patent 9434994Patent 8734778Patent 8715649Patent 8343502Patent 8337830Patent 8221763Patent 8153136Patent 8067559Patent 7910315Patent 7595060Patent 7563447Patent 7465454Patent 7083787

Abstract

ABSTRACT Overview: Functional genomics approaches are a central pillar of modern cancer research. By enabling the manipulation of gene function and quantitative analysis of such perturbations, functional genomic tools contribute to the elucidation of genotype-to-phenotype relationships controlling cancer development and response to therapies. The field of functional genomics, a direct product of the Human Genome Project, has rapidly evolved with the advent of technologies such as RNA interference (RNAi) and rapid genome editing (e.g. CRISPR), which in turn facilitated the investigation of large numbers of genes in vertebrate cells in a single experiment. The Functional Genomics Shared Resource (FGSR) provides UCCC members access to tools that investigate gene function on a genome-wide scale; develops novel protocols and offers expertise for the use of functional genomics tools; and provides a forum for scientific exchange. By promoting collaboration in functional genomics, the FGSR serves to catalyze discoveries by UCCC members. Services: The FGSR provides reagents to members in ready-to-use and cost-effective formats. Additionally, a variety of personalized services like custom design and creation of shRNA and CRISPR panels targeting gene collections of interest, and cell engineering are also offered. Reagents/Tools: Through continuous assessment of novel technologies and UCCC members' needs, the FGSR has acquired genome-wide short hairpin RNA (shRNA), Open Reading Frame (ORF) and CRISPR libraries. The FGSR's human and mouse shRNA collections contain 176,283 clones and 138,538 clones, respectively. The ORF library contains 15,744 plasmids for overexpression of 13,082 unique human genes. The arrayed CRISPR library has 2 gRNAs per gene for 16,190 human genes. The FGSR also houses genome-wide shRNA libraries, myriad of pathway-focused shRNA panels, gene knockout CRISPR libraries like the GeCKO and Brunello and transactivating SAM libraries in ready-to-use format. Management: The FGSR is managed by the UCCC, and is overseen by the Associate Director for Basic Research. Use: Since July 2016, 318 individuals from 146 investigator laboratories have used services. Fifty-nine percent of these teams (86) were UCCC members, representing all four Programs and resulting in 80 peer-reviewed publications. Operating Budget: CCSG funding represents 43% of the annual operating budget and the remaining support is from user fees (30%) and institutional funds (27%). Consultation/Education: FGSR personnel assist members on a daily basis with experimental design and troubleshooting. The FGSR collaborates with other SRs to create robust protocols for seamless use of reagents across SRs. The website hosts a large number of very detailed protocols and bibliographic sources that are updated constantly. The FGSR also hosts `technology forums' where UCCC members are updated on the latest developments and applications in the field. Future Directions: The FGSR will continue to acquire the latest tools in the functional genomics field, such as novel CRISPR-based technologies. The service and education portfolio will be expanded via technology forums and webinars.

View original record on NIH RePORTER →